Before serving under President Barack Obama, Mr. Botticelli served as Director of the Bureau of Substance Abuse Services at the Massachusetts Department of Public Health where he worked closely with BMC, the largest safety-net provider in New England.
“Michael embodies every item on the wish list of what we wanted in the ideal director of the Grayken Center and he is the perfect fit for the Center and its ability to lead in this battle,” said Kate Walsh, CEO of BMC. “Michael was instrumental in getting the fight against addiction to the top of the national agenda. He fought for additional funding and worked closely with groups across the country to develop and replicate clinical treatment programs that work. But he also led the way on shaping our country’s understanding of addiction as a disease, not a moral failing or character flaw, and that patients with substance use disorder deserve treatment not punishment. He is a true leader in addiction medicine.”
Mr. Botticelli holds a Bachelor of Arts degree from Siena College in Albany, N.Y., and a Master of Education degree from St. Lawrence University in Canton, N.Y. Mr. Botticelli is also a recovering addict with more than 28 years of sobriety.
More articles on executive moves:
Dr. Mary Norine Walsh steps into American College of Cardiology president role: 4 points
York General Hospital appoints Jenny Obermier COO & CNO: 3 takeaways
SageWest Health Care taps Alan Daugherty to lead as CEO: 4 notes
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
